According to Pfizer’s trial results, Paxlovid could be used as an alternative to in-hospital treatment for preventing disease progression in patients with the same risk factors.

Pfizer is the second such biopharma company to come up with an antiviral pill. The first one was Mercks which proved to be effective for “first sign of illness”.